Scadding JG: Fibrosing alveolitis [letter]. Br Med J. 1964, 2: 686-
Article
PubMed
CAS
PubMed Central
Google Scholar
American Thoracic Society : Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Amer-ican Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000, 161: 646-664.
Article
Google Scholar
Coultas DB, Zumwalt RE, Black WC, Sobonya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994, 150: 967-973.
Article
PubMed
CAS
Google Scholar
Panos RJ, Mortenson RL, Niccoli SA, King TE: Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990, 88: 396-404.
Article
PubMed
CAS
Google Scholar
Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA: Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997, 155: 242-248.
Article
PubMed
CAS
Google Scholar
Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA: Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicentre case-control study. Collaborating Centres. Am J Epidemiol. 2000, 152: 307-315. 10.1093/aje/152.4.307.
Article
PubMed
CAS
Google Scholar
Hubbard R, Lewis S, Richards K, Johnston I, Britton J: Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet. 1996, 347: 284-289.
Article
PubMed
CAS
Google Scholar
Vergnon JM, Vincent M, DeThe G, Mornex JF, Weynants P, Brune P: Cryptogenic fibrosing alveolitis and Epstein–Barr virus: an association?. Lancet. 1984, 2: 768-771. 10.1016/S0140-6736(84)90702-5.
Article
PubMed
CAS
Google Scholar
Egan JJ, Woodcock AA, Stewart JP: Viruses and idiopathic pulmonary fibrosis. Eur Respir J. 1997, 10: 1433-1437. 10.1183/09031936.97.10071433.
Article
PubMed
CAS
Google Scholar
Wangoo A, Shaw RJ, Diss TC, Farrell PJ, Du Bois RM, Nicholas AG: Cryptogenic fibrosing alveolitis: lack of association with Epstein–Barr virus infection. Thorax. 1997, 52: 888-891.
Article
PubMed
CAS
PubMed Central
Google Scholar
du Bois RM: Cryptogenic fibrosing alveolitis and cryptogenic organising pneumonia. In: Respiratory Medicine, 2nd ed. Edited by Brewis RAL, Corrin B, Geddes DM, Gibson GJ. London: Saunders;. 1996, 1377-1393.
Google Scholar
Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998, 157: 1301-1315.
Article
PubMed
CAS
Google Scholar
Majumdar S, Li D, Ansari T, Pantelidis P, Black CM, Gizycki M, du Bois RM, Jeffery PK: Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. Eur Respir J. 1999, 14: 251-257. 10.1034/j.1399-3003.1999.14b03.x.
Article
PubMed
CAS
Google Scholar
Khalil N, O'Connor RN, Flanders KC, Unruh H: TGF-beta 1 but not TGF-beta 2 or TGF-beta 3 is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol. 1996, 14: 131-138.
Article
PubMed
CAS
Google Scholar
Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH: A preliminary study of long-term treatment with interferon Gamma-1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 1999, 341: 1264-1269. 10.1056/NEJM199910213411703.
Article
PubMed
CAS
Google Scholar
Turner Warwick M, Doniach D: Autoantibody studies in interstitial pulmonary fibrosis. Br Med J. 1965, 1: 886-891.
Article
PubMed
CAS
PubMed Central
Google Scholar
Chapman JR, Charles PJ, Venables PJ, Thompson PJ, Haslam PL, Maini RN, Turner-Warwick ME: Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1984, 130: 439-443.
PubMed
CAS
Google Scholar
Meliconi R, Bestagno M, Sturani C, Negri C, Galavotti V, Sala C, Facchini A, Ciarrocchi G, Gasbarrini G, Astaldi Ricotti GC: Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol. 1989, 76: 184-189.
PubMed
CAS
PubMed Central
Google Scholar
Dobashi N, Fujita J, Ohtsuki Y, Yamadori I, Yoshinouchi T, Kamei T, Tokuda M, Hojo S, Bandou S, Ueda Y, Takahara J: Circulating cytokeratin 8:anti-cytokeratin 8 antibody immune complexes in sera of patients with pulmonary fibrosis. Respiration. 2000, 67: 397-401. 10.1159/000029537.
Article
PubMed
CAS
Google Scholar
Dreisen RB, Schwarz MI, Theofilopoulos AN, Stanford RE: Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med. 1978, 298: 353-358.
Article
Google Scholar
Dall'Aglio PP, Pesci A, Bertorelli G, Brianti E, Scarpa S: Study of immune complexes in bronchoalveolar lavage fluids. Respiration. 1988, 54 (suppl 1): 36-41.
Article
Google Scholar
Wallace WA, Roberts SN, Caldwell H, Thornton E, Greening AP, Lamb D, Howie SE: Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax. 1994, 49: 218-222.
Article
PubMed
CAS
PubMed Central
Google Scholar
Wallace WA, Schofield JA, Lamb D, Howie SE: Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax. 1994, 49: 1139-1145.
Article
PubMed
CAS
PubMed Central
Google Scholar
Robinson C, Callow M, Stevenson S, Robinson BWS, Lake RA: Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis. Respiratory Research. 2001.
Google Scholar
Robinson C, Callow M, Stevenson S, Scott BS, Robinson BWS, Lake RA: Serologic responses in patients with malignant mesothelioma. Evidence for both public and private specificities. Am J Respir Cell Biol. 2000, 22: 550-556.
Article
CAS
Google Scholar